Neurobiological Technologies, Inc.
NTII · OTC
6/30/2010 | 6/30/2009 | 6/30/2008 | 6/30/2007 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | -$0 | $0 |
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | 78.5% | -16.5% | – |
| Gross Profit | – | $0 | $0 | $0 |
| % Margin | – | 99.5% | 98.6% | 98.7% |
| EBITDA | – | $0 | -$0 | -$0 |
| % Margin | – | 12.4% | -111.7% | -87% |
| Net Income | – | $0 | -$0 | -$0 |
| % Margin | – | 11.9% | -110.6% | -79.9% |
| EPS Diluted | – | 0.12 | -0.84 | -3.26 |
| % Growth | – | 114.3% | 74.2% | – |
| Operating Cash Flow | – | -$0 | -$0 | -$0 |
| Capital Expenditures | – | -$0 | -$0 | -$0 |
| Free Cash Flow | – | -$0 | -$0 | -$0 |